BULLISH, It's supper undervalued. $19-$20 cash on hand, 1 million float, 1.4 million O/S, The company confirmed there will be zero need to dilute via ATM offering. They recently got granted EPO patent, FDA news should be out very soon.
2 gaps need to filled on the way up, keep an eye on it. with $19-$20 million cash on hand, a price target of $10 is fairly valued even without FDA granted.
2 gaps need to filled on the way up, keep an eye on it. with $19-$20 million cash on hand, a price target of $10 is fairly valued even without FDA granted.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。